Vid is the CEO and co-founder of Kuano, a startup focussing on drug design for enzyme disease targets using a combination of molecular simulations and AI. Vid is an expert in quantum physics, tensor networks, machine learning and mathematical modelling with over 15 years of postdoctoral experience at leading centres including University of Hamburg, University of Vienna, University of Ghent and University College London.